Hyundai Pharmaceutical Co., Ltd. (KRX: 004310)
South Korea flag South Korea · Delayed Price · Currency is KRW
3,450.00
+5.00 (0.15%)
Nov 15, 2024, 3:30 PM KST

Hyundai Pharmaceutical Income Statement

Millions KRW. Fiscal year is Dec - Nov.
Fiscal Year
TTM FY 2013 FY 2012 FY 2011 FY 2010 FY 2009 2008 - 2004
Period Ending
Nov '13 Nov '13 Nov '12 Nov '11 Nov '10 Nov '09 2008 - 2004
Operating Revenue
108,135108,135102,253114,276111,860122,879
Upgrade
Other Revenue
00-0---
Upgrade
Revenue
108,135108,135102,253114,276111,860122,879
Upgrade
Revenue Growth (YoY)
5.75%5.75%-10.52%2.16%-8.97%1.96%
Upgrade
Cost of Revenue
67,64467,64463,18368,59266,33173,697
Upgrade
Gross Profit
40,49140,49139,07145,68445,52949,182
Upgrade
Selling, General & Admin
37,36037,36041,99741,07644,41744,588
Upgrade
Research & Development
67.6967.69391.59165.4659.631,813
Upgrade
Other Operating Expenses
452.61452.61325.58374.22561.25598.7
Upgrade
Operating Expenses
38,30438,30443,39042,22346,41248,012
Upgrade
Operating Income
2,1872,187-4,3193,460-882.81,171
Upgrade
Interest Expense
-973.72-973.72-1,269-1,355-1,273-1,213
Upgrade
Interest & Investment Income
517.65517.65527.68386.47560.86703.49
Upgrade
Earnings From Equity Investments
----146.24-9.29
Upgrade
Currency Exchange Gain (Loss)
160160141.22122.07147.191,519
Upgrade
Other Non Operating Income (Expenses)
-1,081-1,081-1,065-742.52-41.63-477.09
Upgrade
EBT Excluding Unusual Items
810.3810.3-5,9831,871-1,3431,694
Upgrade
Gain (Loss) on Sale of Investments
--2.8314.9-487.31
Upgrade
Gain (Loss) on Sale of Assets
340.5340.5-233.65-92.685,137-262.18
Upgrade
Pretax Income
1,1511,151-6,2141,7933,7941,919
Upgrade
Income Tax Expense
-308.81-308.81-1,3661,250825.86248.73
Upgrade
Earnings From Continuing Operations
1,4601,460-4,848542.942,9681,671
Upgrade
Minority Interest in Earnings
-44.73-44.73-2.16-22.84--
Upgrade
Net Income
1,4151,415-4,850520.12,9681,671
Upgrade
Net Income to Common
1,4151,415-4,850520.12,9681,671
Upgrade
Net Income Growth
----82.48%77.67%-51.93%
Upgrade
Shares Outstanding (Basic)
232323242425
Upgrade
Shares Outstanding (Diluted)
232323242425
Upgrade
Shares Change (YoY)
0.09%0.09%-0.89%-0.97%-2.94%-7.44%
Upgrade
EPS (Basic)
60.3460.34-207.0022.00124.3367.93
Upgrade
EPS (Diluted)
60.3460.34-207.0022.00124.3367.93
Upgrade
EPS Growth
----82.31%83.04%-48.07%
Upgrade
Free Cash Flow
5,7105,710-4,1542,586-1,267-9,216
Upgrade
Free Cash Flow Per Share
243.49243.49-177.31109.37-53.09-374.72
Upgrade
Dividend Per Share
42.00042.000--45.00050.000
Upgrade
Dividend Growth
-----10.00%-23.08%
Upgrade
Gross Margin
37.44%37.44%38.21%39.98%40.70%40.02%
Upgrade
Operating Margin
2.02%2.02%-4.22%3.03%-0.79%0.95%
Upgrade
Profit Margin
1.31%1.31%-4.74%0.46%2.65%1.36%
Upgrade
Free Cash Flow Margin
5.28%5.28%-4.06%2.26%-1.13%-7.50%
Upgrade
EBITDA
4,2984,298-1,9625,9301,4063,775
Upgrade
EBITDA Margin
3.97%3.97%-1.92%5.19%1.26%3.07%
Upgrade
D&A For EBITDA
2,1112,1112,3572,4702,2892,605
Upgrade
EBIT
2,1872,187-4,3193,460-882.81,171
Upgrade
EBIT Margin
2.02%2.02%-4.22%3.03%-0.79%0.95%
Upgrade
Effective Tax Rate
---69.72%21.77%12.96%
Upgrade
Revenue as Reported
----111,860122,879
Upgrade
Advertising Expenses
7,2057,2057,8587,67311,08612,080
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.